New pill for eczema shows promise in early safety trial
NCT ID NCT06945458
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This early-stage study tested an oral medication called KT-621 in 22 adults with moderate to severe atopic dermatitis (eczema). The main goal was to check the drug's safety and how the body handles it. Researchers monitored side effects and drug levels in the blood. This is a first step to see if the drug is safe enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kymera Investigative Site
Birmingham, Alabama, 35244, United States
-
Kymera Investigative Site
Fountain Valley, California, 92708, United States
-
Kymera Investigative Site
Santa Monica, California, 90404, United States
-
Kymera Investigative Site
Boynton Beach, Florida, 33436, United States
-
Kymera Investigative Site
Hollywood, Florida, 33024, United States
-
Kymera Investigative Site
Tampa, Florida, 33613, United States
-
Kymera Investigative Site
Fargo, North Dakota, 58078, United States
-
Kymera Investigative Site
Dublin, Ohio, 43016, United States
-
Kymera Investigative Site
Springfield, Ohio, 45505, United States
-
Kymera Investigative Site
Tulsa, Oklahoma, 74136, United States
-
Kymera Investigative Site
Charleston, South Carolina, 29420, United States
-
Kymera Investigative Site
San Antonio, Texas, 78213, United States
Conditions
Explore the condition pages connected to this study.